Clostridium difficile is responsible for more than 250,000 hospitalizations and 15,000 U.S. deaths each year.
Kateryna Kon/Shutterstock
CALIFORNIA–(ENEWSPF)–September 24, 2015. Stanford University School of Medicine scientists successfully defeated a dangerous intestinal pathogen, Clostridium difficile, with a drug targeting its toxins rather than its life.
By not aiming to kill the pathogen with antibiotics, scientists were able to avoid wiping out sizable numbers of beneficial gut microbes. And while their study was performed in mice, the drug used has already…
